Pay in 4 interest-free payments of $6.03 Learn more
Ships within 48 hours · Estimated delivery Oct 30 - Nov 4
Different injection sites
This isnt entirely new
The initiative builds on work the agency did with MedeAnalytics to create the nation's first Medicaid clinical data exchange with health care providers
doi: 10.1093/brain/aws009 13
Preferential cytogenetic response to continuous intravenous low-exposure level [PMID: 17644749] Laboratory literature summary: Preferential cytogenetic response to continuous intravenous low-exposure level decitabine (DAC) administration in myelodysplastic
US$ 27.30
US$ 20.87
US$ 26.34
US$ 27.89
